Exploitation of necroptosis for treatment of caspase–compromised cancers (Review)

Oncology Letters

Volumn 14, Issue 2, 2017, Pages 1207-1214

  Cho, Young Sik ^a   Park, Hey Li ^a  

^a Keimyung University   (South Korea)

Author keywords

Anticancer therapy; Apoptosis; Necroptosis; Programmed necrosis

Indexed keywords

CASPASE INHIBITOR; INTERFERON; PEPTIDES AND PROTEINS; RECEPTOR INTERACTING PROTEIN KINASE 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL DEATH; CELLULAR IMMUNITY; HUMAN; HUNTINGTON CHOREA; MYCOBACTERIUM TUBERCULOSIS; NECROPTOSIS; NONHUMAN; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

EID: 85021705764     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2017.6285     Document Type: Article

References (57)

1. Fulda S, Gorman AM, Hori O and Samali A: Cellular stress responses: Cell survival and cell death. Int J Cell Biol 2010: 214074, 2010.
2. Haanen C and Vermes I: Apoptosis: Programmed cell death in fetal development. Eur J Obstet Gynecol Reprod Biol 64: 129-133, 1996.
3. Opferman JT: Apoptosis in the development of the immune system. Cell Death Differ 15: 234-242, 2008.
4. Duval D, Trouillas M, Thibault C, Dembelé D, Diemunsch F, Reinhardt B, Mertz AL, Dierich A and Boeuf H: Apoptosis and differentiation commitment: Novel insights revealed by gene profiling studies in mouse embryonic stem cells. Cell Death Differ 13: 564-575, 2006.
5. Elliott MR and Ravichandran KS: Clearance of apoptotic cells: Implications in health and disease. J Cell Biol 189: 1059-1070, 2010.
6. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 15: 135-147, 2014.
7. Giampietri C, Starace D, Petrungaro S, Filippini A and Ziparo E: Necroptosis: Molecular signalling and translational implications. Int J Cell Biol 2014: 490275, 2014.
8. Lu JV, Chen HC and Walsh CM: Necroptotic signaling in adaptive and innate immunity. Semin Cell Dev Biol 35: 33-39, 2014.
9. Fulda S: The mechanism of necroptosis in normal and cancer cells. Cancer Biol Ther 14: 999-1004, 2013.
10. Zhou W and Yuan J: Necroptosis in health and diseases. Semin Cell Dev Biol 35: 14-23, 2014.
11. Kaczmarek A, Vandenabeele P and Krysko DV: Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 38: 209-223, 2013.
12. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M and Chan FK: Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123, 2009.
13. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ and Yuan J: Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135: 1311-1323, 2008.
14. Festjens N, Vanden Berghe T, Cornelis S and Vandenabeele P: RIP1, a kinase on the crossroads of a cell’s decision to live or die. Cell Death Differ 14: 400-410, 2007.
15. Micheau O and Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190, 2003.
16. Han J, Zhong CQ and Zhang DW: Programmed necrosis: Backup to and competitor with apoptosis in the immune system. Nat Immunol 12: 1143-1149, 2011.
17. Moquin DM, McQuade T and Chan FK: CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS One 8: e76841, 2013.
18. Moriwaki K and Chan FK: RIP3: A molecular switch for necrosis and inflammation. Genes Dev 27: 1640-1649, 2013.
19. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X and Wang X: Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148: 213-227, 2012.
20. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J and Liu ZG: Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 109: 5322-5327, 2012.
21. Wang Z, Jiang H, Chen S, Du F and Wang X: The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148: 228-243, 2012.
22. Remijsen Q, Goossens V, Grootjans S, Van den Haute C, Vanlangenakker N, Dondelinger Y, Roelandt R, Bruggeman I, Goncalves A, Bertrand MJ, et al: Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis 5: e1004, 2014.
23. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, et al: Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4: 313-321, 2008.
24. Liao D, Sun L, Liu W, He S, Wang X and Lei X: Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein. Med Chem Comm 5: 333-337, 2014.
25. Christofferson DE and Yuan J: Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22: 263-268, 2010.
26. Bohgaki T, Mozo J, Salmena L, Matysiak-Zablocki E, Bohgaki M, Sanchez O, Strasser A, Hakem A and Hakem R: Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/-mice. J Cell Biol 195: 277-291, 2011.
27. Upton JW, Kaiser WJ and Mocarski ES: Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7: 302-313, 2010.
28. Desvignes L, Wolf AJ and Ernst JD: Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J Immunol 188: 6205-6215, 2012.
29. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L and Sad S: Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 13: 954-962, 2012.
30. He S, Wang L, Miao L, Wang T, Du F, Zhao L and Wang X: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100-1111, 2009.
31. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF and Becker C: Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477: 335-339, 2011.
32. Trichonas G, Murakami Y, Thanos A, Morizane Y, Kayama M, Debouck CM, Hisatomi T, Miller JW and Vavvas DG: Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 107: 21695-21700, 2010.
33. Linkermann A, De Zen F, Weinberg J, Kunzendorf U and Krautwald S: Programmed necrosis in acute kidney injury. Nephrol Dial Transplant 27: 3412-3419, 2012.
34. Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX and Jaeschke H: Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58: 2099-2108, 2013.
35. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H, et al: Activation of necroptosis in multiple sclerosis. Cell Rep 10: 1836-1849, 2015.
36. Kitur K, Parker D, Nieto P, Ahn DS, Cohen TS, Chung S, Wachtel S, Bueno S and Prince A: Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog 11: e1004820, 2015.
37. Su Z, Yang Z, Xie L, DeWitt JP and Chen Y: Cancer therapy in the necroptosis era. Cell Death Differ 23: 748-756, 2016.
38. Meng MB, Wang HH, Cui YL, Wu ZQ, Shi YY, Zaorsky NG, Deng L, Yuan ZY, Lu Y and Wang P: Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Oncotarget 7: 57391-57413, 2016.
39. Liu P, Xu B, Shen W, Zhu H, Wu W, Fu Y, Chen H, Dong H, Zhu Y, Miao K, et al: Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: Suppression of CYLD gene by LEF 1. Leukemia 26: 1293-1300, 2012.
40. Wu W, Liu P and Li J: Necroptosis: An emerging form of programmed cell death. Crit Rev Oncol Hemato 82: 249-258, 2012.
41. Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N and Sarkar S: Drug resistance in cancer: An overview. Cancers (Basel) 6: 1769-1792, 2014.
42. McCabe KE, Bacos K, Lu D, Delaney JR, Axelrod J, Potter MD, Vamos M, Wong V, Cosford ND, Xiang R and Stupack DG: Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma. Cell Death Dis 5: e1496, 2014.
43. Basit F, Cristofanon S and Fulda S: Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ 20: 1161-1173, 2013.
44. Dunai ZA, Imre G, Barna G, Korcsmaros T, Petak I, Bauer PI and Mihalik R: Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS One 7: e41945, 2012.
45. Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY: Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene 32: 2973-2983, 2013.
46. Kaku Y, Tsuchiya A, Kanno T and Nishizaki T: HUHS1015 induces necroptosis and caspase-independent apoptosis of MKN28 human gastric cancer cells in association with AMID accumulation in the nucleus. Anticancer Agents Med Chem 15: 242-247, 2015.
47. Pasupuleti N, Leon L, Carraway KL, III and Gorin F: 5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor. J Pharmacol Exp Ther 344: 600-615, 2013.
48. Huang C, Luo Y, Zhao J, Yang F, Zhao H, Fan W and Ge P: Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One 8: e66326, 2013.
49. Fu Z, Deng B, Liao Y, Shan L, Yin F, Wang Z, Zeng H, Zuo D, Hua Y and Cai Z: The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Cancer 13: 580, 2013.
50. Tian W, Deng Y, Li L, He H, Sun J and Xu D: Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death. Int J Oncol 42: 721-732, 2013.
51. Miki Y, Akimoto J, Moritake K, Hironaka C and Fujiwara Y: Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells. Lasers Med Sci 30: 1739-1745, 2015.
52. Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore FD Jr and Ruan DT: Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery 150: 1032-1039, 2011.
53. Liu T, Bao YH, Wang Y and Jiang JY: The role of necroptosis in neurosurgical diseases. Braz J Med Biol Res 48: 292-298, 2015.
54. Yamanaka K, Saito Y, Yamamori T, Urano Y and Noguchi N: 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. J Biol Chem 286: 24666-24673, 2011.
55. Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F, et al: RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res 103: 206-216, 2014.
56. King MD, Whitaker-Lea WA, Campbell JM, Alleyne CH Jr and Dhandapani KM: Necrostatin-1 reduces neurovascular injury after intracerebral hemorrhage. Int J Cell Biol 2014: 495817, 2014.
57. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS and Wang X: Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP 3. Mol Cell 54: 133-146, 2014.